WNK2 and neoplasm: According to the 5th edition of the WHO classification, it is categorized as a tumor of the macrophage-dendritic cell lineage and is recognized as an inflammatory myeloid neoplasm driven by mutations in the mitogen-activated protein kinase (MAPK) pathway [2].